GlaxoSmithKline Pharmaceuticals
PUBLIC
STATUS
1K-5K
EMPLOYEES
500660
STOCK SYMBOL
2
INVESTMENTS
$19.11
SHARE PRICE
(As of Friday Closing)
Description
GlaxoSmithKline Pharmaceuticals Ltd is a drug manufacturing company that focuses on researching and developing pharmaceutical medicines, vaccines and consumer healthcare products. A vast majority of the company's revenue is derived from operations in the United States, followed by Europe. The company manages three main businesses in pharmaceuticals, vaccines, and consumer healthcare. The bulk of the company's revenue is generated through the pharmaceuticals business, followed by consumer healthcare.
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
- Mumbai
- India
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore GlaxoSmithKline Pharmaceuticals’s full profile, request a free trial.
GlaxoSmithKline Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $16.36 - $24.23 | $3.24B | $19.25 | $0.40 | 2.63K | 169M |
GlaxoSmithKline Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
FY 2017
31-Mar-2017
|
|---|---|---|---|---|
| Enterprise Value | 2,916,245 | 2,972,013 | 5,411,952 | 6,946,166 |
| Revenue | 450,182 | 446,922 | 445,384 | 433,601 |
| EBITDA | 101,185 | 94,883 | 81,510 | 69,424 |
| Net Income | 67,214 | 63,634 | 54,400 | 50,213 |
| Total Assets | 563,190 | 606,333 | 463,191 | |
| Total Debt | 84 | 152 | 246 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
GlaxoSmithKline Pharmaceuticals Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 13-May-2016 | 00000 00000 00 | 00000 | Biotechnology | |
| Silarus Therapeutics | 22-Sep-2014 | Early Stage VC | 0000 | Drug Discovery |